Search clinical trials for: Serotonin

Total 4661 results

Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Bipolar I Disorder

Japan
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH); Duke University

Completed

FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders (AripfMRI)

Autism Spectrum Disorder

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Bipolar I Disorder

Taiwan, Korea, Republic of, Japan, China
Seoul National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

Bipolar Disorders | Metabolic Complication

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Bipolar I Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Patients With Bipolar I Disorder

Bipolar Disorder

France, Portugal, Spain, Italy, Germany, South Africa, United Kingdom, United States, Russian Federation, Poland, Czech Republic, Hungary, Netherlands, Estonia, Australia, Bulgaria, Switzerland
Otsuka Pharmaceutical Development & Commercialization...

Completed

Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Withdrawn

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Bipolar Disorder

United States, India
Massachusetts General Hospital
Bristol-Myers Squibb

Completed

Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder

Bipolar Disorder | Mania

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia (ASPIRE)

Schizophrenia

United States, Argentina, Bulgaria, India, Malaysia, Mexico, Philippines, Romania, Russian Federation, Serbia, Slovakia, Taiwan
GlaxoSmithKline

Completed

A PET Study in Healthy Volunteers

Depressive Disorder

United Kingdom
University of Texas Southwestern Medical Center
Bristol-Myers Squibb

Completed

Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression

Major Depressive Disorder

United States
New Mexico VA Healthcare System
Bristol-Myers Squibb

Unknown

Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole

Schizophrenia | Sensory Gating

United States
Federal University of Rio Grande do Sul

Completed

Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD

Bipolar Disorder | Attention Deficit Hyperactivity Disorder

Brazil
University of Calgary
Janssen Inc.

Completed

Prucalopride Versus Placebo in Gastroparesis

Diabetes Mellitus | Gastroparesis

Canada
University of British Columbia

Unknown

Prucalopride Prior to Small Bowel Capsule Endoscopy

Intestinal Diseases | Inflammatory Bowel Diseases | Celiac Disease | Crohn Disease | Gastrointestinal Hemorrhage

Canada
NuPathe Inc.

Completed

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers (NP101-006)

Migraine Disorders

United States
Pfizer

Completed

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Migraine

United States
Mayo Clinic
ARYx Therapeutics

Completed

Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers

Healthy

United States
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

Healthy

Canada
Movetis

Completed

Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility

Constipation
All India Institute of Medical Sciences, Bhubaneswar

Recruiting

Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia

Schizophrenia

India
Consorcio Centro de Investigación Biomédica en...
Instituto de Salud Carlos III

Not yet recruiting

Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis (SchizOMICS)

Diabetes | Schizophrenia | Lipid Metabolism Disorders | NAFLD | Psychosis | Treatment-resistant Schizophrenia | Side Effect
Otsuka Pharmaceutical Development & Commercialization...
PRA Health Sciences

Completed

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

Schizophrenia | Bipolar I Disorder

United States
Ain Shams University

Completed

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

Analgesia | Anesthesia | Hysterotomy

Egypt
University of Medicine and Dentistry of New Jersey

Completed

Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children (Abilify)

Autism

United States
University of Copenhagen

Completed

Pan European Collaboration on Antipsychotic Naïve Schizophrenia II (PECANSII)

Schizophrenia

Denmark
Chonbuk National University Hospital
Otsuka Pharmaceutical Co., Ltd.

Completed

Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients

Schizophrenia

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia

Schizophrenia

Japan
Kettering Health Network

Terminated

Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia (BEST)

Schizophrenia

United States
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Unknown

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up (PAFIP3_1Y)

Psychotic Disorders | Schizophrenia

Spain
Medical University of South Carolina

Completed

Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART) (BAART)

Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia

Schizophrenia

United States
Weill Medical College of Cornell University

Completed

SSRI Effects on Semen Parameters in Men

Healthy

United States
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Unknown

Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition

Bioequivalence

China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Autistic Disorder

Japan
Craig Rush
National Institute on Drug Abuse (NIDA)

Completed

Aripiprazole to Reduce Cocaine Relapse

Cocaine-Related Disorders

United States
Northwell Health
National Institute of Mental Health (NIMH)

Completed

Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis

Schizophrenia

United States
St. Luke's-Roosevelt Hospital Center
Bristol-Myers Squibb

Completed

Abilify as an Adjunctive Treatment for Refractory Depression

Depressive Disorder, Major

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia (STEP 203)

Schizophrenia

United States, Croatia, Serbia, Bulgaria, India, Korea, Republic of, Philippines, Romania, Russian Federation, Slovakia, Taiwan, Ukraine
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
University of Oxford
National Institute for Health Research, United Kingdom

Completed

Aripiprazole and Prolactin Study (APS)

Hyperprolactinemia

United Kingdom
Otsuka Pharmaceutical Development & Commercialization...

Withdrawn

Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder

Nervous System Diseases | Schizophrenia | Mental Disorder | Bipolar 1 Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials

Schizophrenia

France, South Africa, Canada, Russian Federation, Poland, Czech Republic, Hungary, Croatia, Netherlands, Romania, United Kingdom
University Hospitals Cleveland Medical Center
Bristol-Myers Squibb

Completed

Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

Attention Deficit Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

Schizophrenia

United States
Indiana University School of Medicine
Bristol-Myers Squibb

Completed

A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.

Asperger's Disorder | Pervasive Developmental Disorder

United States
University of North Carolina, Chapel Hill
Bristol-Myers Squibb

Completed

Study of Aripiprazole to Treat Children and Adolescents With Autism (PAIRS)

Autism Spectrum Disorder | Autistic Disorder | Asperger Syndrome

United States

Search clinical trials for: Serotonin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations